CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trialRob Coleman, Sarah Brown, A.W. Reid et al.|Trials|2020Cited by 15
A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial resultsMatthew Winter, Janet E. Brown, Rob Coleman et al.|Journal of bone oncology|2022Cited by 10